ZIOPHARM ONCOLOGY INC's ticker is and the CUSIP is 98973P901. A total of 3 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,042 | -79.5% | 91,400 | -20.5% | 0.00% | – |
| Q2 2023 | $58,650 | -57.3% | 115,000 | -47.2% | 0.00% | – |
| Q1 2023 | $137,340 | -44.6% | 218,000 | -42.9% | 0.00% | -100.0% |
| Q4 2022 | $247,761 | -68.2% | 381,700 | -15.8% | 0.00% | -50.0% |
| Q3 2022 | $780,000 | +251.4% | 453,400 | +153.7% | 0.00% | – |
| Q2 2022 | $222,000 | -10.8% | 178,700 | -53.2% | 0.00% | – |
| Q1 2022 | $249,000 | -75.3% | 382,000 | -58.8% | 0.00% | -100.0% |
| Q4 2021 | $1,009,000 | -35.8% | 926,100 | +7.3% | 0.00% | -50.0% |
| Q3 2021 | $1,571,000 | +42.6% | 863,400 | +106.9% | 0.00% | +100.0% |
| Q2 2021 | $1,102,000 | -50.7% | 417,400 | -32.8% | 0.00% | -66.7% |
| Q1 2021 | $2,235,000 | +153.1% | 620,900 | +77.1% | 0.00% | +50.0% |
| Q4 2020 | $883,000 | -37.0% | 350,500 | -36.9% | 0.00% | -50.0% |
| Q3 2020 | $1,401,000 | -18.1% | 555,900 | +6.7% | 0.00% | -50.0% |
| Q2 2020 | $1,710,000 | +43.6% | 521,200 | +7.2% | 0.01% | -20.0% |
| Q1 2020 | $1,191,000 | -54.7% | 486,300 | -12.6% | 0.01% | -44.4% |
| Q4 2019 | $2,627,000 | +32.7% | 556,600 | +20.3% | 0.02% | +12.5% |
| Q3 2019 | $1,980,000 | +1.8% | 462,500 | +38.6% | 0.02% | -11.1% |
| Q2 2019 | $1,945,000 | +29.0% | 333,600 | -14.9% | 0.02% | +5.9% |
| Q1 2019 | $1,508,000 | +108.6% | 391,800 | +1.3% | 0.02% | +183.3% |
| Q4 2018 | $723,000 | +563.3% | 386,700 | +1034.0% | 0.01% | +500.0% |
| Q3 2018 | $109,000 | -23.8% | 34,100 | -28.2% | 0.00% | 0.0% |
| Q2 2018 | $143,000 | -84.7% | 47,500 | -80.0% | 0.00% | -88.9% |
| Q1 2018 | $932,000 | +262.6% | 237,800 | +283.5% | 0.01% | +350.0% |
| Q4 2017 | $257,000 | -76.5% | 62,000 | -65.2% | 0.00% | -80.0% |
| Q3 2017 | $1,095,000 | -42.8% | 178,300 | -42.1% | 0.01% | -50.0% |
| Q2 2017 | $1,914,000 | -3.9% | 307,700 | -2.1% | 0.02% | -13.0% |
| Q1 2017 | $1,992,000 | +1.9% | 314,200 | -14.0% | 0.02% | +21.1% |
| Q4 2016 | $1,954,000 | -37.0% | 365,300 | -33.7% | 0.02% | -44.1% |
| Q3 2016 | $3,104,000 | +9.6% | 551,300 | +6.9% | 0.03% | 0.0% |
| Q2 2016 | $2,832,000 | -25.0% | 515,800 | +1.3% | 0.03% | -35.8% |
| Q1 2016 | $3,778,000 | -12.1% | 509,200 | -1.5% | 0.05% | +3.9% |
| Q4 2015 | $4,297,000 | -35.9% | 517,100 | -30.5% | 0.05% | -45.2% |
| Q3 2015 | $6,708,000 | -14.4% | 744,500 | +14.0% | 0.09% | -15.5% |
| Q2 2015 | $7,834,000 | -31.2% | 652,800 | -38.2% | 0.11% | -38.5% |
| Q1 2015 | $11,379,000 | +546.2% | 1,056,500 | +204.2% | 0.18% | +563.0% |
| Q4 2014 | $1,761,000 | +145.3% | 347,300 | +27.7% | 0.03% | +145.5% |
| Q3 2014 | $718,000 | -22.0% | 272,000 | +19.0% | 0.01% | -21.4% |
| Q2 2014 | $921,000 | -65.5% | 228,600 | -60.8% | 0.01% | -68.9% |
| Q1 2014 | $2,673,000 | -20.3% | 583,600 | -24.5% | 0.04% | -11.8% |
| Q4 2013 | $3,355,000 | +85.2% | 773,100 | +68.5% | 0.05% | +45.7% |
| Q3 2013 | $1,812,000 | +132.9% | 458,800 | +23.9% | 0.04% | +84.2% |
| Q2 2013 | $778,000 | – | 370,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 257,300 | $33 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 91,400 | $12,042 | 0.00% |